Cannabis in Canada: Implications for nursing in a changing legal and health-care landscape
Recorded Tuesday, June 27, 2017, 12-1p.m. ET
CERTIFICATE OF PARTICIPATION:
The use of cannabis both recreationally and medically has shifted significantly in Canada. New legislation, a growing body of research, and changing attitudes towards cannabis as a controlled substance all have an impact on nursing.
Register for this free webinar to:
• Discover recent policy changes
• Learn the risks and benefits of cannabis use
• Explore the stigma surrounding cannabis in the context of health care and Canadian society
• Understand the implications for nursing with regards to balancing the risks of recreational cannabis with the potential benefits of medical cannabis
Lynda Balneaves, RN, PhD
Lynda Balneaves is an associate professor in the University of Manitoba’s college of nursing. For the past 20 years she has focused her research on supporting informed treatment decisions in people living with cancer interested in using complementary therapies. Balneaves is the the principal investigator of the Complementary Medicine Education and Outcomes (CAMEO) research program, which has developed and evaluated a variety of education and decision support interventions aimed at helping cancer patients and health professionals make evidence-informed decisions about complementary therapies. She has also conducted health services and policy research on the use of medical cannabis in Canada. Currently, Balneaves is the president-elect of the Society for Integrative Oncology and is board member for the International Society for Complementary Medicine Research organization. She has received the Canadian Cancer Society Research Scientist Award and the CIHR New Investigator Award. She was also honoured to receive the College of Registered Nurses of British Columbia’s Award of Excellence for Nursing Research in 2012 and the Canadian Association Nurses in Oncology’s Pfizer Oncology Canada Award of Excellence in Oncology Nursing Research in 2010.